UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MIB-1 Proliferative Activity Is a Significant Prognostic Factor in Primary Thick Cutaneous Melanomas

Journal of investigative dermatology, 1995-07, Vol.105 (1), p.22-26

1995

Volltextzugriff (PDF)

Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer

Canadian Medical Association journal, 1999-01, Vol.160 (1), p.70

1999

Volltextzugriff (PDF)

Extragonadal germ cell tumors. A 14‐year Toronto experience

Cancer, 1994-04, Vol.73 (7), p.1971-1979

1994

Volltextzugriff (PDF)

Prostate cancer screening: waiting for Godot

Canadian Medical Association journal (CMAJ), 1998-12, Vol.159 (11), p.1375

Iscoe, N A

1998

Volltextzugriff (PDF)

Prostate cancer: 1. The descriptive epidemiology in Canada

Canadian Medical Association journal, 1998-09, Vol.159 (5), p.509

1998

Volltextzugriff (PDF)

Trends in Hormonal Management of Prostate Cancer: A Population-Based Study in Ontario

Medical care, 2001-04, Vol.39 (4), p.384-396

2001

Volltextzugriff (PDF)

Prostate cancer: 10. Palliative care

Canadian Medical Association journal (CMAJ), 1999-02, Vol.160 (3), p.365

1999

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group

Journal of clinical oncology, 1996-07, Vol.14 (7), p.2083-2090

1996

Volltextzugriff (PDF)

Phase II study of trimetrexate in malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group study

Investigational new drugs, 1990-02, Vol.8 (1), p.121-123

1990

Volltextzugriff (PDF)

Fat oxidation rate and the exercise intensity that elicits maximal fat oxidation decreases with pubertal status in young male subjects

Journal of applied physiology (1985), 2008-08, Vol.105 (2), p.742-748

2008

Volltextzugriff (PDF)

Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma

International journal of radiation oncology, biology, physics, 2005-03, Vol.61 (3), p.736-740

2005

Volltextzugriff (PDF)

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer

Annals of oncology, 2008-05, Vol.19 (5), p.939-945

2008

Volltextzugriff (PDF)

Phase I Trial of Radiation With Concurrent and Consolidation Pemetrexed and Cisplatin in Patients With Unresectable Stage IIIA/B Non–Small-Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2011-04, Vol.79 (5), p.1395-1401

2011

Volltextzugriff (PDF)

Hypercapnia improves tissue oxygenation

Anesthesiology (Philadelphia), 2002-10, Vol.97 (4), p.801-806

2002

Volltextzugriff (PDF)

Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100

Cancer, 2006-02, Vol.106 (4), p.890-899

2006

Volltextzugriff (PDF)

A Phase II Study of Methotrexate, Vinblastine, Doxorubicin and Cisplatin Plus Recombinant Human Granulocyte-Macrophage Colony Stimulating Factors in Patients with Advanced Transitional Cell Carcinoma

The Journal of urology, 1993-10, Vol.150 (4), p.1131-1134

1993

Volltextzugriff (PDF)

Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients

Annals of internal medicine, 1988-04, Vol.108 (4), p.554

1988

Volltextzugriff (PDF)

The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine

Journal of pain and symptom management, 1992-10, Vol.7 (7), p.384-392

1992

Volltextzugriff (PDF)

Predicting psychological distress in patients with cancer: conceptual basis and reliability evaluation of a self-report questionnaire

Anticancer research, 1995-07, Vol.15 (4), p.1533

1995

Volltextzugriff (PDF)

A phase II study of spirogermanium in patients with metastatic malignant melanoma. An NCI Canada Clinical Trials Group Study

Investigational new drugs, 1985-01, Vol.3 (3), p.303-305

1985

Volltextzugriff (PDF)

Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma

Cancer treatment reports, 1985-09, Vol.69 (9), p.941

1985

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Humans
(21)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Adult
(15)
Aged
(15)
Female
(15)
Middle Aged
(15)
Biological And Medical Sciences
(10)
Oncology
(9)
Medical Sciences
(8)
General & Internal Medicine
(6)
Medicine, General & Internal
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Aged, 80 And Over
(4)
Antineoplastic Agents
(4)
Cancer
(4)
Melanoma - Drug Therapy
(4)
Pharmacology. Drug Treatments
(4)
Prostate Cancer
(4)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MIB-1 Proliferative Activity Is a Significant Prognostic Factor in Primary Thick Cutaneous Melanomas

Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer

Extragonadal germ cell tumors. A 14‐year Toronto experience

Prostate cancer screening: waiting for Godot

Prostate cancer: 1. The descriptive epidemiology in Canada

Trends in Hormonal Management of Prostate Cancer: A Population-Based Study in Ontario

Prostate cancer: 10. Palliative care

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group

Phase II study of trimetrexate in malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group study

Fat oxidation rate and the exercise intensity that elicits maximal fat oxidation decreases with pubertal status in young male subjects

Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer

Phase I Trial of Radiation With Concurrent and Consolidation Pemetrexed and Cisplatin in Patients With Unresectable Stage IIIA/B Non–Small-Cell Lung Cancer

Hypercapnia improves tissue oxygenation

Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100

A Phase II Study of Methotrexate, Vinblastine, Doxorubicin and Cisplatin Plus Recombinant Human Granulocyte-Macrophage Colony Stimulating Factors in Patients with Advanced Transitional Cell Carcinoma

Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in outpatients

The evaluation of analgesic effects in cancer patients as exemplified by a double-blind, crossover study of immediate-release versus controlled-release morphine

Predicting psychological distress in patients with cancer: conceptual basis and reliability evaluation of a self-report questionnaire

A phase II study of spirogermanium in patients with metastatic malignant melanoma. An NCI Canada Clinical Trials Group Study

Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma

Aktive Filter

Suchergebnisse filtern